[Federal Register Volume 70, Number 38 (Monday, February 28, 2005)]
[Notices]
[Page 9677]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-3798]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 13, 2005, Boehringer 
Ingelheim Chemical Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
Tetrahydrocannabinols (7370), a basic class of controlled substance 
listed in Schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for use in analysis and drug test standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than [60 days from 
publication].

    Dated: February 17, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-3798 Filed 2-25-05; 8:45 am]
BILLING CODE 4410-09-P